10-104002922-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_014720.4(SLK):āc.1744C>Gā(p.Gln582Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000217 in 1,613,962 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_014720.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLK | NM_014720.4 | c.1744C>G | p.Gln582Glu | missense_variant | 9/19 | ENST00000369755.4 | NP_055535.2 | |
SLK | NM_001304743.2 | c.1744C>G | p.Gln582Glu | missense_variant | 9/18 | NP_001291672.1 | ||
SLK | XM_011540401.4 | c.993+1350C>G | intron_variant | XP_011538703.1 | ||||
SLK | XM_047426039.1 | c.993+1350C>G | intron_variant | XP_047281995.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLK | ENST00000369755.4 | c.1744C>G | p.Gln582Glu | missense_variant | 9/19 | 1 | NM_014720.4 | ENSP00000358770 | P1 | |
SLK | ENST00000335753.8 | c.1744C>G | p.Gln582Glu | missense_variant | 9/18 | 1 | ENSP00000336824 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152050Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000518 AC: 13AN: 251136Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135758
GnomAD4 exome AF: 0.0000130 AC: 19AN: 1461794Hom.: 0 Cov.: 33 AF XY: 0.0000151 AC XY: 11AN XY: 727198
GnomAD4 genome AF: 0.000105 AC: 16AN: 152168Hom.: 0 Cov.: 32 AF XY: 0.000161 AC XY: 12AN XY: 74376
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 15, 2021 | The c.1744C>G (p.Q582E) alteration is located in exon 9 (coding exon 9) of the SLK gene. This alteration results from a C to G substitution at nucleotide position 1744, causing the glutamine (Q) at amino acid position 582 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at